NCT04125563View on ClinicalTrials.gov

Influence on Cough and Airway Symptoms by Oral Capsaicin

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

December 30, 2025

Study Completion Date

June 15, 2026

Conditions
Cough
Interventions
DRUG

Capsicum Oleoresin

The soft gel capsules used in the study are easily digested in the stomach and contain standardised doses of 0,4 mg Capsicum oleoresin with the main component capsaicin (8-methyl-N-vanillyl-6-nonenamide) (from chili extract).

DRUG

Placebos

Soft gel capsules filled with placebo - sorbitol and colorant.

Trial Locations (1)

413 45

Allergy clinic, Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Sahlgrenska University Hospital

OTHER

collaborator

Vinnova

OTHER_GOV

lead

Vastra Gotaland Region

OTHER_GOV

NCT04125563 - Influence on Cough and Airway Symptoms by Oral Capsaicin | Biotech Hunter | Biotech Hunter